USANA Health Sciences - 30 Year Stock Price History | USNA

Historical daily share price chart and data for USANA Health Sciences since 1995 adjusted for splits and dividends. The latest closing stock price for USANA Health Sciences as of February 07, 2025 is 30.65.
  • The all-time high USANA Health Sciences stock closing price was 136.25 on July 25, 2018.
  • The USANA Health Sciences 52-week high stock price is 52.75, which is 72.1% above the current share price.
  • The USANA Health Sciences 52-week low stock price is 30.39, which is 0.8% below the current share price.
  • The average USANA Health Sciences stock price for the last 52 weeks is 41.67.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
USANA Health Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 33.8292 36.3900 36.3900 30.6500 30.6500 -14.60%
2024 43.2890 54.4500 54.4500 33.3800 35.8900 -33.04%
2023 59.0943 54.4600 67.9200 44.4400 53.6000 0.75%
2022 71.1160 102.9400 102.9400 48.6600 53.2000 -47.43%
2021 96.8984 77.9500 106.4500 77.9500 101.2000 31.26%
2020 76.4390 77.9000 91.2000 45.7800 77.1000 -1.85%
2019 80.8571 116.5500 118.9700 58.9200 78.5500 -33.28%
2018 106.8860 74.9500 136.2500 70.7500 117.7300 58.99%
2017 61.8281 62.2000 75.6000 54.2500 74.0500 21.00%
2016 62.6045 63.6050 74.1250 47.4100 61.2000 -4.19%
2015 62.7007 51.1400 88.0600 48.9650 63.8750 24.52%
2014 39.3646 38.4700 59.0900 28.8100 51.2950 35.74%
2013 32.5806 16.4400 45.7050 16.4400 37.7900 129.52%
2012 20.2209 15.7650 24.6250 15.4600 16.4650 8.43%
2011 15.9897 21.8300 21.8300 11.8000 15.1850 -30.10%
2010 18.7135 16.2250 22.5350 12.3200 21.7250 36.21%
2009 14.2776 16.6800 18.4950 9.2950 15.9500 -6.83%
2008 15.9444 18.0500 24.7400 9.3150 17.1200 -7.66%
2007 22.2569 26.2300 30.8000 14.7400 18.5400 -28.22%
2006 21.1419 18.9150 26.2200 17.9550 25.8300 34.67%
2005 21.9370 16.9550 26.5400 16.5250 19.1800 12.16%
2004 14.7882 14.8950 18.2500 11.6650 17.1000 11.76%
2003 9.6598 2.9700 19.2000 2.9700 15.3000 407.88%
2002 1.3397 0.3625 3.0125 0.2900 3.0125 895.87%
2001 0.4610 0.3275 0.7200 0.3025 0.3025 -19.33%
2000 0.9648 1.1875 1.8750 0.3200 0.3750 -70.00%
1999 2.1249 2.5000 4.3125 1.0300 1.2500 -50.59%
1998 3.4142 2.2650 5.6875 2.1875 2.5300 11.70%
1997 2.0547 2.2650 2.6725 1.1563 2.2650 0.67%
1996 2.4225 1.3125 3.8750 1.0938 2.2500 59.99%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.595B $0.921B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.557B 30.23
Chugai Pharmaceutical (CHGCY) Japan $73.258B 28.91
Takeda Pharmaceutical (TAK) Japan $43.305B 9.58
Sandoz Group AG (SDZNY) Switzerland $21.476B 0.00
Merck (MKKGY) Germany $19.083B 17.09
Astellas Pharma (ALPMY) Japan $16.957B 12.01
United Therapeutics (UTHR) United States $15.793B 15.54
Summit Therapeutics (SMMT) United States $15.243B 0.00
Neurocrine Biosciences (NBIX) United States $15.239B 45.75
Shionogi (SGIOY) Japan $12.318B 12.34
Orion OYJ (ORINY) Finland $7.466B 20.99
Madrigal Pharmaceuticals (MDGL) United States $7.203B 0.00
Corcept Therapeutics (CORT) United States $7.129B 54.00
Stevanato Group S.p.A (STVN) Italy $6.808B 44.08
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.152B 0.00
Grifols, S.A (GRFS) Spain $4.806B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.779B 9.78
Crinetics Pharmaceuticals (CRNX) United States $3.590B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.829B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.750B 12.47
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.469B 14.76
Centessa Pharmaceuticals (CNTA) United Kingdom $2.352B 0.00
Soleno Therapeutics (SLNO) United States $2.198B 0.00
Hypermarcas (HYPMY) Brazil $2.068B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.949B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.808B 0.00
Dyne Therapeutics (DYN) United States $1.706B 0.00
Evotec AG (EVO) Germany $1.666B 0.00
Indivior (INDV) United States $1.468B 5.98
Guardian Pharmacy Services (GRDN) United States $1.408B 0.00
Ardelyx (ARDX) United States $1.343B 0.00
ARS Pharmaceuticals (SPRY) United States $1.244B 0.00
Xencor (XNCR) United States $1.207B 0.00
Ocular Therapeutix (OCUL) United States $1.201B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.158B 0.00
Harrow (HROW) United States $1.105B 0.00
Enliven Therapeutics (ELVN) United States $1.098B 0.00
Collegium Pharmaceutical (COLL) United States $0.998B 5.45
Bioventus (BVS) United States $0.880B 27.80
Cronos Group (CRON) Canada $0.773B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.771B 0.00
Relay Therapeutics (RLAY) United States $0.755B 0.00
Verve Therapeutics (VERV) United States $0.708B 0.00
Elite Pharmaceuticals (ELTP) United States $0.556B 0.00
Xeris Biopharma Holdings (XERS) United States $0.540B 0.00
OmniAb (OABI) United States $0.524B 0.00
Altimmune (ALT) United States $0.491B 0.00
Savara (SVRA) United States $0.487B 0.00
ProKidney (PROK) United States $0.484B 0.00
KalVista Pharmaceuticals (KALV) United States $0.475B 0.00
Akebia Therapeutics (AKBA) United States $0.471B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.468B 0.00
Oruka Therapeutics (ORKA) United States $0.458B 0.00
Organogenesis (ORGO) United States $0.446B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.430B 174.21
Zevra Therapeutics (ZVRA) United States $0.421B 0.00
Siga Technologies (SIGA) United States $0.413B 4.82
Tourmaline Bio (TRML) United States $0.384B 0.00
Esperion Therapeutics (ESPR) United States $0.365B 0.00
Aldeyra Therapeutics (ALDX) United States $0.357B 0.00
Korro Bio (KRRO) United States $0.339B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.310B 0.00
4D Molecular Therapeutics (FDMT) United States $0.301B 0.00
CytoDyn (CYDY) United States $0.277B 0.00
Aquestive Therapeutics (AQST) United States $0.275B 0.00
Heron Therapeutics (HRTX) United States $0.272B 0.00
Nature's Sunshine Products (NATR) United States $0.271B 16.10
Amylyx Pharmaceuticals (AMLX) United States $0.257B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
Avita Medical (RCEL) United States $0.240B 0.00
Larimar Therapeutics (LRMR) United States $0.229B 0.00
MediWound (MDWD) Israel $0.210B 0.00
Acrivon Therapeutics (ACRV) United States $0.203B 0.00
Profound Medical (PROF) Canada $0.184B 0.00
Lexeo Therapeutics (LXEO) United States $0.179B 0.00
Aclaris Therapeutics (ACRS) United States $0.174B 0.00
Lyell Immunopharma (LYEL) United States $0.173B 0.00
Silence Therapeutics (SLN) United Kingdom $0.172B 0.00
Inhibikase Therapeutics (IKT) United States $0.169B 0.00
VAXART, INC (VXRT) United States $0.168B 0.00
Nanobiotix S.A (NBTX) France $0.166B 0.00
Champions Oncology (CSBR) United States $0.147B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.138B 0.00
Telomir Pharmaceuticals (TELO) United States $0.135B 0.00
Nektar Therapeutics (NKTR) United States $0.129B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Cassava Sciences (SAVA) United States $0.113B 0.00
Achieve Life Sciences (ACHV) Canada $0.110B 0.00
ElectroCore (ECOR) United States $0.106B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.106B 0.00
Journey Medical (DERM) United States $0.104B 0.00
Inotiv (NOTV) United States $0.102B 0.00
Protara Therapeutics (TARA) United States $0.100B 0.00
Metagenomi (MGX) United States $0.099B 0.00
Pyxis Oncology (PYXS) United States $0.087B 0.00
Arch Biopartners (ACHFF) Canada $0.086B 0.00
Avalo Therapeutics (AVTX) United States $0.085B 0.00
Regulus Therapeutics (RGLS) United States $0.083B 0.00
Karyopharm Therapeutics (KPTI) United States $0.083B 0.00
Galectin Therapeutics (GALT) United States $0.083B 0.00
Fractyl Health (GUTS) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.20
ESSA Pharma (EPIX) Canada $0.075B 0.00
Mural Oncology (MURA) Ireland $0.075B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 0.00
Nutriband (NTRB) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.074B 0.00
Gain Therapeutics (GANX) United States $0.070B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Context Therapeutics (CNTX) United States $0.067B 0.00
Century Therapeutics (IPSC) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
AleAnna (ANNA) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
FibroGen (FGEN) United States $0.050B 0.00
AlloVir (ALVR) United States $0.050B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Rafael Holdings (RFL) United States $0.049B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Incannex Healthcare (IXHL) Australia $0.039B 0.00
Surrozen (SRZN) United States $0.036B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
BioVie (BIVI) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.031B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Traws Pharma (TRAW) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Scienture Holdings (SCNX) United States $0.029B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.021B 0.00
Carisma Therapeutics (CARM) United States $0.021B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.021B 0.00
Lipocine (LPCN) United States $0.020B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
Dominari Holdings (DOMH) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Phio Pharmaceuticals (PHIO) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Ainos (AIMD) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.007B 0.00
BioLineRx (BLRX) Israel $0.007B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
SHINECO (SISI) China $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Aditxt (ADTX) United States $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00